054180 — Medicox Co Income Statement

0.000.00%

Last trade - 00:00

IndustrialsHighly SpeculativeMicro Cap

Annual income statement for Medicox Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	R2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,449	20,296	26,875	30,611	28,161
Cost of Revenue
Gross Profit	505	569	1,921	2,038	2,168
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	34,455	43,288	35,493	43,836	34,541
Operating Profit	-17,006	-22,992	-8,618	-13,225	-6,380
Total Net Non Operating Interest Income / Expense
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-23,938	-41,804	-31,152	-21,497	-11,766
Provision for Income Taxes
Net Income After Taxes	-23,938	-41,804	-31,152	-21,424	-11,895
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	-23,935	-42,619	-34,427	-21,435	-11,895
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	-23,935	-42,619	-34,427	-21,435	-11,895
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-18,452	-21,544	-17,185	-5,046	-2,032
Dividends per Share